Mammalian target of rapamycin inhibition attenuates myocardial ischaemia–reperfusion injury in hypertrophic heart

Pathological cardiac hypertrophy aggravated myocardial infarction and is causally related to autophagy dysfunction and increased oxidative stress. Rapamycin is an inhibitor of serine/threonine kinase mammalian target of rapamycin (mTOR) involved in the regulation of autophagy as well as oxidative/nitrative stress. Here, we demonstrated that rapamycin ameliorates myocardial ischaemia reperfusion injury by rescuing the defective cytoprotective mechanisms in hypertrophic heart. Our results showed that chronic rapamycin treatment markedly reduced the phosphorylated mTOR and ribosomal protein S6 expression, but not Akt in both normal and aortic‐banded mice. Moreover, chronic rapamycin treatment significantly mitigated TAC‐induced autophagy dysfunction demonstrated by prompted Beclin‐1 activation, elevated LC3‐II/LC3‐I ratio and increased autophagosome abundance. Most importantly, we found that MI/R‐induced myocardial injury was markedly reduced by rapamycin treatment manifested by the inhibition of myocardial apoptosis, the reduction of myocardial infarct size and the improvement of cardiac function in hypertrophic heart. Mechanically, rapamycin reduced the MI/R‐induced iNOS/gp91phox protein expression and decreased the generation of NO and superoxide, as well as the cytotoxic peroxynitrite. Moreover, rapamycin significantly mitigated MI/R‐induced endoplasmic reticulum stress and mitochondrial impairment demonstrated by reduced Caspase‐12 activity, inhibited CHOP activation, decreased cytoplasmic Cyto‐C release and preserved intact mitochondria. In addition, inhibition of mTOR also enhanced the phosphorylated ERK and eNOS, and inactivated GSK3β, a pivotal downstream target of Akt and ERK signallings. Taken together, these results suggest that mTOR signalling protects against MI/R injury through autophagy induction and ERK‐mediated antioxidative and anti‐nitrative stress in mice with hypertrophic myocardium.

[1]  Jun Ren,et al.  Complex inhibition of autophagy by mitochondrial aldehyde dehydrogenase shortens lifespan and exacerbates cardiac aging. , 2017, Biochimica et biophysica acta. Molecular basis of disease.

[2]  Anindita Das,et al.  Reperfusion Therapy with Rapamycin Attenuates Myocardial Infarction through Activation of AKT and ERK , 2017, Oxidative medicine and cellular longevity.

[3]  Yang Li,et al.  Hypercholesterolemia Abrogates Remote Ischemic Preconditioning-Induced Cardioprotection: Role of Reperfusion Injury Salvage Kinase Signals , 2017, Shock.

[4]  L. Køber,et al.  Left Ventricular Hypertrophy Is Associated With Increased Infarct Size and Decreased Myocardial Salvage in Patients With ST‐Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention , 2017, Journal of the American Heart Association.

[5]  C. Drummond,et al.  Rapamycin Attenuates Cardiac Fibrosis in Experimental Uremic Cardiomyopathy by Reducing Marinobufagenin Levels and Inhibiting Downstream Pro‐Fibrotic Signaling , 2016, Journal of the American Heart Association.

[6]  T. Minamino,et al.  Physiological and pathological cardiac hypertrophy. , 2016, Journal of molecular and cellular cardiology.

[7]  M. E. Shaker,et al.  The novel TLR9 antagonist COV08-0064 protects from ischemia/reperfusion injury in non-steatotic and steatotic mice livers. , 2016, Biochemical pharmacology.

[8]  Joseph A. Hill,et al.  Therapeutic targeting of autophagy in cardiovascular disease. , 2016, Journal of molecular and cellular cardiology.

[9]  Y. Maejima,et al.  Drp1-Dependent Mitochondrial Autophagy Plays a Protective Role Against Pressure Overload–Induced Mitochondrial Dysfunction and Heart Failure , 2016, Circulation.

[10]  T. Engstrøm,et al.  Increased myocardial vulnerability to ischemia–reperfusion injury in the presence of left ventricular hypertrophy , 2016, Journal of hypertension.

[11]  T. Matsui,et al.  Cardiac mTOR rescues the detrimental effects of diet-induced obesity in the heart after ischemia-reperfusion. , 2015, American journal of physiology. Heart and circulatory physiology.

[12]  Y. Liao,et al.  Pharmacological modulation of autophagy to protect cardiomyocytes according to the time windows of ischaemia/reperfusion , 2015, British journal of pharmacology.

[13]  R. Franco,et al.  Oxidative stress, redox signaling, and autophagy: cell death versus survival. , 2014, Antioxidants & redox signaling.

[14]  Jun Ren,et al.  Macrophage Migration Inhibitory Factor Deletion Exacerbates Pressure Overload–Induced Cardiac Hypertrophy Through Mitigating Autophagy , 2014, Hypertension.

[15]  B. Kalyanaraman,et al.  On the use of fluorescence lifetime imaging and dihydroethidium to detect superoxide in intact animals and ex vivo tissues: a reassessment. , 2014, Free radical biology & medicine.

[16]  M. Volpe,et al.  Mammalian target of rapamycin signaling in cardiac physiology and disease. , 2014, Circulation research.

[17]  Mark A Sussman,et al.  Mechanistic Target of Rapamycin Complex 2 Protects the Heart From Ischemic Damage , 2013, Circulation.

[18]  Mark A Sussman,et al.  mTORC2 Protects the Heart from Ischemic Damage , 2013 .

[19]  Jun Ren,et al.  MTOR overactivation and interrupted autophagy flux in obese hearts , 2013, Autophagy.

[20]  P. Pagliaro,et al.  Mitochondrial pathways, permeability transition pore, and redox signaling in cardioprotection: therapeutic implications. , 2013, Antioxidants & redox signaling.

[21]  Anindita Das,et al.  Rapamycin protects against myocardial ischemia-reperfusion injury through JAK2-STAT3 signaling pathway. , 2012, Journal of molecular and cellular cardiology.

[22]  N. King,et al.  Propofol improves recovery of the isolated working hypertrophic heart from ischaemia–reperfusion , 2012, Pflügers Archiv - European Journal of Physiology.

[23]  I. Komuro,et al.  Association of Stat3 with HSF1 plays a critical role in G-CSF-induced cardio-protection against ischemia/reperfusion injury. , 2012, Journal of molecular and cellular cardiology.

[24]  U. Förstermann,et al.  Nitric oxide synthases: regulation and function. , 2012, European heart journal.

[25]  Lei Zhao,et al.  Extracellular signal-regulated kinase 1/2 activation is involved in intermedin1–53 attenuating myocardial oxidative stress injury induced by ischemia/reperfusion , 2012, Peptides.

[26]  P. Pagliaro,et al.  Ischemia/reperfusion injury is increased and cardioprotection by a postconditioning protocol is lost as cardiac hypertrophy develops in nandrolone treated rats , 2011, Basic Research in Cardiology.

[27]  Dian J. Cao,et al.  Histone deacetylase (HDAC) inhibitors attenuate cardiac hypertrophy by suppressing autophagy , 2011, Proceedings of the National Academy of Sciences.

[28]  K. Shimamoto,et al.  Hypertensive Hypertrophied Myocardium Is Vulnerable to Infarction and Refractory to Erythropoietin-Induced Protection , 2011, Hypertension.

[29]  S. Sollott,et al.  Role of Glycogen Synthase Kinase-3β in Cardioprotection , 2009, Circulation research.

[30]  Lei Xi,et al.  ERK phosphorylation mediates sildenafil-induced myocardial protection against ischemia-reperfusion injury in mice. , 2009, American journal of physiology. Heart and circulatory physiology.

[31]  Yajing Wang,et al.  INO-4885 [5,10,15,20-Tetra[N-(benzyl-4′-carboxylate)-2-pyridinium]-21H,23H-porphine Iron(III) Chloride], a Peroxynitrite Decomposition Catalyst, Protects the Heart against Reperfusion Injury in Mice , 2009, Journal of Pharmacology and Experimental Therapeutics.

[32]  Mehregan Movassagh,et al.  Simplified apoptotic cascades , 2008, Heart Failure Reviews.

[33]  J. Richardson,et al.  Cardiac autophagy is a maladaptive response to hemodynamic stress. , 2007, The Journal of clinical investigation.

[34]  B. Vidne,et al.  The protective effect of prior ischemia reperfusion adenosine A1 or A3 receptor activation in the normal and hypertrophied heart. , 2007, Interactive cardiovascular and thoracic surgery.

[35]  Yasushi Matsumura,et al.  The role of autophagy in cardiomyocytes in the basal state and in response to hemodynamic stress , 2007, Nature Medicine.

[36]  Walter Koch,et al.  Adiponectin Cardioprotection After Myocardial Ischemia/Reperfusion Involves the Reduction of Oxidative/Nitrative Stress , 2007, Circulation.

[37]  W. Paulus,et al.  Peroxynitrite-induced alpha-actinin nitration and contractile alterations in isolated human myocardial cells. , 2005, Cardiovascular research.

[38]  M. Hall,et al.  The expanding TOR signaling network. , 2005, Current opinion in cell biology.

[39]  W. Manning,et al.  Rapamycin Attenuates Load-Induced Cardiac Hypertrophy in Mice , 2003, Circulation.

[40]  D. Heistad,et al.  Gene transfer of endothelial nitric oxide synthase improves relaxation of carotid arteries from diabetic rabbits. , 2000, Circulation.

[41]  D E Manyari,et al.  Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. , 1990, The New England journal of medicine.